Natixis Advisors, L.P. Abbott Laboratories Transaction History

Natixis Advisors, L.P.

$51.3 Billion
Q3 2024

A detailed history of Natixis Advisors, L.P. transactions in Abbott Laboratories stock. As of the latest transaction made, Natixis Advisors, L.P. holds 1,423,015 shares of ABT stock, worth $165 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

1,423,015

Previous 1,218,537 16.78%

Holding current value

$165 Million

Previous $127 Million 28.13%

% of portfolio

0.32%

Previous 0.28%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$100.07 - $118.13 $20.5 Million - $24.2 Million	204,478 Added 16.78%	1,423,015 $162 Million
Q2 2024 Aug 01, 2024	BUY	$100.73 - $112.44 $24.4 Million - $27.2 Million	242,239 Added 24.81%	1,218,537 $127 Million
Q1 2024 Apr 25, 2024	BUY	$109.52 - $120.96 $1.14 Million - $1.25 Million	10,368 Added 1.07%	976,298 $111 Million
Q4 2023 Feb 06, 2024	BUY	$90.19 - $110.4 $23.7 Million - $29.1 Million	263,186 Added 37.45%	965,930 $106 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $40.2 Million - $48.3 Million	-421,202 Reduced 37.48%	702,744 $68.1 Million
Q2 2023 Aug 15, 2023	BUY	$100.78 - $112.29 $21.9 Million - $24.4 Million	217,661 Added 24.02%	1,123,946 $123 Million
Q1 2023 May 11, 2023	SELL	$96.86 - $114.01 $15.5 Million - $18.2 Million	-159,612 Reduced 14.97%	906,285 $91.8 Million
Q4 2022 Jan 27, 2023	BUY	$95.06 - $111.52 $7.11 Million - $8.34 Million	74,766 Added 7.54%	1,065,897 $117 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $13.3 Million - $15.4 Million	137,412 Added 16.1%	991,131 $95.9 Million
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $6.7 Million - $8.1 Million	-65,640 Reduced 7.14%	853,719 $92.8 Million
Q1 2022 May 12, 2022	BUY	$114.02 - $139.04 $913,984 - $1.11 Million	8,016 Added 0.88%	919,359 $109 Million
Q4 2021 Feb 08, 2022	BUY	$115.53 - $141.46 $6.2 Million - $7.59 Million	53,627 Added 6.25%	911,343 $128 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $3.52 Million - $3.9 Million	30,193 Added 3.65%	857,716 $101 Million
Q2 2021 Aug 12, 2021	BUY	$105.79 - $124.53 $3.28 Million - $3.86 Million	31,026 Added 3.9%	827,523 $95.9 Million
Q1 2021 May 05, 2021	BUY	$108.84 - $128.23 $2.39 Million - $2.81 Million	21,943 Added 2.83%	796,497 $95.5 Million
Q4 2020 Feb 12, 2021	BUY	$105.0 - $114.42 $13.8 Million - $15 Million	131,493 Added 20.45%	774,554 $84.8 Million
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $3.18 Million - $3.86 Million	-34,716 Reduced 5.12%	643,061 $70 Million
Q2 2020 Aug 11, 2020	BUY	$76.57 - $98.0 $9.64 Million - $12.3 Million	125,952 Added 22.82%	677,777 $62 Million
Q1 2020 Apr 27, 2020	BUY	$62.82 - $91.86 $1.02 Million - $1.5 Million	16,281 Added 3.04%	551,825 $43.5 Million
Q4 2019 Feb 10, 2020	BUY	$78.51 - $87.4 $5.46 Million - $6.08 Million	69,534 Added 14.92%	535,544 $46.5 Million
Q3 2019 Nov 12, 2019	BUY	$81.84 - $88.74 $3.44 Million - $3.73 Million	42,076 Added 9.93%	466,010 $39 Million
Q2 2019 Aug 12, 2019	SELL	$72.88 - $85.0 $1.91 Million - $2.23 Million	-26,218 Reduced 5.82%	423,934 $35.7 Million
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $553,930 - $669,701	8,365 Added 1.89%	450,152 $36 Million
Q4 2018 Feb 13, 2019	BUY	$65.56 - $74.27 $9.05 Million - $10.3 Million	138,020 Added 45.44%	441,787 $32 Million
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $773,685 - $933,359	-12,723 Reduced 4.02%	303,767 $22.3 Million
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $705,750 - $778,936	12,259 Added 4.03%	316,490 $0
Q1 2018 May 10, 2018	SELL	$56.27 - $63.62 $526,518 - $595,292	-9,357 Reduced 2.98%	304,231 $18.2 Million
Q4 2017 Feb 14, 2018	SELL	$53.68 - $57.47 $5.97 Million - $6.39 Million	-111,236 Reduced 26.18%	313,588 $17.9 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $20.4 Million - $22.8 Million	424,824	424,824 $22.7 Million

Others Institutions Holding ABT

# of Institutions

3,184

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.

Account

Natixis Advisors, L.P. Abbott Laboratories Transaction History